Autocrine and paracrine growth inhibitors of breast cancer cells

X L Bourhis1, R A Toillon, B Boilly

  • 1Laboratoire de Biologie du Développement , Université des Sciences et Technologies de Lille, Villeneuve d' Ascq, France. Xuefen.Lebourhis@univ-lille1.fr

Insights

This review explores breast epithelial cell growth inhibitors, focusing on their roles in mammary gland development and potential links to breast cancer. Understanding these inhibitors is crucial for developing new therapeutic strategies.

Area of Science:

  • Cell Biology
  • Endocrinology
  • Oncology

Background:

  • Breast epithelial cells regulate mammary gland development via autocrine and paracrine signaling.
  • Growth factors are well-studied, but the role of growth inhibitors remains less understood.
  • Inhibitors may play a significant role in controlling cell proliferation and preventing abnormal growth.

Purpose of the Study:

  • To review current knowledge on major autocrine and paracrine growth inhibitors of breast epithelial cells.
  • To discuss the potential functions of these inhibitors in breast cancer development.
  • To highlight the importance of growth inhibitors in understanding mammary gland homeostasis.

Main Methods:

  • Literature review of scientific publications.
  • Synthesis of information on identified growth inhibitors.
  • Analysis of proposed mechanisms of action and signaling pathways.

Main Results:

  • Identification of key autocrine and paracrine growth inhibitors.
  • Overview of their established and proposed functions in normal breast tissue.
  • Discussion of their potential involvement in the pathogenesis of breast cancer.

Conclusions:

  • Growth inhibitors are critical regulators of breast epithelial cell proliferation.
  • Further research into these inhibitors may reveal novel therapeutic targets for breast cancer.
  • Understanding the balance between mitogens and inhibitors is essential for mammary gland health.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Autocrine Signaling01:54

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.Autocrine Signaling in MacrophagesUnder normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...